Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_15551
http://purl.obolibrary.org/obo/CHEBI_15551
|
|---|---|
| Preferred Name | prostaglandin E2 |
| Synonyms |
Dinoproston
dinoprostone
Prostin E2
(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
dinoprostona
dinoprostonum
Prepidil
PGE2
(Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(15S)-prostaglandin E2
Dinoprostone
(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
Propess
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
C20H32O5
Prostaglandin E2
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | prostaglandin E2
|
|---|---|
| label | prostaglandin E2
|
| DBSynonym |
dinoprostone prostaglandin e2
pge2
prostaglandin e2
|
| ATCCode | G02AD02
|
| Definition | Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
|
| altId |
CHEBI:8512
CHEBI:114125
CHEBI:26323
CHEBI:4625
CHEBI:10911
CHEBI:10910
See more
See less
|
| has pharmacological target | |
| induces | |
| activates | |
| inhibits |
See more
See less
|
| type | |
| has role | |
| InChIKey | InChIKey=XEYBRNLFEZDVAW-ARSRFYASSA-N
|
| is metabolised by | |
| AHFScode | 76:00.00
|
| Synonym |
Dinoproston
dinoprostone
Prostin E2
(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoic acid
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
dinoprostona
dinoprostonum
Prepidil
PGE2
(Z)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(15S)-prostaglandin E2
Dinoprostone
(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
Propess
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
C20H32O5
Prostaglandin E2
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
See more
See less
|
| xref |
Drugs Product Database (DPD):2231047
PubChem Substance:46505549
ChEBI:15551
Patent:GB851827
BindingDB:35847
KEGG DRUG:D00079
CASRN:363-24-6
Guide To Pharmacology:1916
Wikipedia:http://en.wikipedia.org/wiki/Dinoprostone
DrugBank:DB00917
IUPHAR:1916
Beilstein:2224724
Wikipedia:Prostaglandin_E2
PharmGKB:PA449345
National Drug Code Directory:0009-3359-02
LIPID MAPS:LMFA03010003
Patent:DE2011969
RxList:http://www.rxlist.com/cgi/generic/dinoprostone.htm
Patent:NL6505799
ChemSpider:4444059
Patent:US3598858
KEGG COMPOUND:C00584
PubChem Compound:5280360
Drugs.com:http://www.drugs.com/cdi/dinoprostone-gel.html
See more
See less
|
| CASRN | 363-24-6
|
| prefixIRI | obo2:CHEBI_15551
|
| is transported by |
See more
See less
|
| SMILES |
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1C\\C=C/CCCC(O)=O
|
| may interact with | |
| DBname | dinoprostone
|
| InChI | InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1
|
| DBBrand |
prostin e2
prepidil
prostarmon e
cervidil
prostin e
propess
See more
See less
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |